Tricks with tetramers: how to get the most from multimeric peptide–MHC
暂无分享,去创建一个
D. Price | A. Sewell | L. Wooldridge | H. A. van den Berg | D. Cole | Linda Wooldridge | A. Lissina | Anna Lissina | David K. Cole | Hugo A. Van Den Berg | David A. Price | Andrew K. Sewell | D. Price
[1] D. Speiser,et al. Alpha 3 domain mutants of peptide/MHC class I multimers allow the selective isolation of high avidity tumor-reactive CD8 T cells. , 2003, Journal of Immunology.
[2] P. Marrack,et al. Detection of antigen-specific T cells with multivalent soluble class II MHC covalent peptide complexes. , 1998, Immunity.
[3] Yi Li,et al. Design of Soluble Recombinant T Cell Receptors for Antigen Targeting and T Cell Inhibition* , 2005, Journal of Biological Chemistry.
[4] D. Tuveson,et al. A soluble divalent class I major histocompatibility complex molecule inhibits alloreactive T cells at nanomolar concentrations. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[5] A. Sewell,et al. High Avidity Antigen-Specific CTL Identified by CD8-Independent Tetramer Staining 1 , 2003, The Journal of Immunology.
[6] Jay A. Berzofsky,et al. High-Avidity CTL Exploit Two Complementary Mechanisms to Provide Better Protection Against Viral Infection Than Low-Avidity CTL , 2001, The Journal of Immunology.
[7] Horst Vogel,et al. CD8 kinetically promotes ligand binding to the T-cell antigen receptor. , 2005, Biophysical journal.
[8] J. McCluskey,et al. T-cell receptor bias and immunity. , 2008, Current opinion in immunology.
[9] D. Speiser,et al. α3 Domain Mutants of Peptide/MHC Class I Multimers Allow the Selective Isolation of High Avidity Tumor-Reactive CD8 T Cells1 , 2003, The Journal of Immunology.
[10] J. E. Brewer,et al. The HLA A*0201–restricted hTERT540–548 peptide is not detected on tumor cells by a CTL clone or a high-affinity T-cell receptor , 2007, Molecular Cancer Therapeutics.
[11] Mark M. Davis,et al. Chronic myelogenous leukemia shapes host immunity by selective deletion of high-avidity leukemia-specific T cells. , 2003, The Journal of clinical investigation.
[12] R. Zinkernagel,et al. Induction and Exhaustion of Lymphocytic Choriomeningitis Virus–specific Cytotoxic T Lymphocytes Visualized Using Soluble Tetrameric Major Histocompatibility Complex Class I–Peptide Complexes , 1998, The Journal of experimental medicine.
[13] E. Palmer,et al. A Role for the α-Chain Connecting Peptide Motif in Mediating TCR-CD8 Cooperation , 2002, The Journal of Immunology.
[14] J. Altman,et al. Viral Immune Evasion Due to Persistence of Activated T Cells Without Effector Function , 1998, The Journal of experimental medicine.
[15] R. Zamoyska,et al. Co‐capping studies reveal CD8/TCR interactions after capping CD8β polypeptides and intracellular associations of CD8 with p56lck , 1998, European journal of immunology.
[16] B. Walker,et al. Defining the directionality and quality of influenza virus-specific CD8+ T cell cross-reactivity in individuals infected with hepatitis C virus. , 2008, The Journal of clinical investigation.
[17] D. Plas,et al. Negative regulation of antigen receptor signaling in lymphocytes , 1998, Journal of Molecular Medicine.
[18] E. Palmer,et al. A role for the alpha-chain connecting peptide motif in mediating TCR-CD8 cooperation. , 2002, Journal of immunology.
[19] M. Alexander-Miller,et al. Differential expansion and survival of high and low avidity cytotoxic T cell populations during the immune response to a viral infection. , 2000, Cellular immunology.
[20] R. Phillips,et al. Anti‐coreceptor antibodies profoundly affect staining with peptide‐MHC class I and class II tetramers , 2006, European journal of immunology.
[21] M. Alexander-Miller,et al. Cutting Edge: CD8+ T Cell Clones Possess the Potential to Differentiate into both High- and Low-Avidity Effector Cells1 , 2007, The Journal of Immunology.
[22] Andrew K. Sewell,et al. Human TCR-Binding Affinity is Governed by MHC Class Restriction1 , 2007, The Journal of Immunology.
[23] S. Mark,et al. Soluble MHC-Peptide Complexes Induce Rapid Death of CD8+ CTL1 , 2005, The Journal of Immunology.
[24] F. Wurm,et al. CD8beta endows CD8 with efficient coreceptor function by coupling T cell receptor/CD3 to raft-associated CD8/p56(lck) complexes. , 2001 .
[25] G. Boivin,et al. A Single-Chain Class II MHC-IgG3 Fusion Protein Inhibits Autoimmune Arthritis by Induction of Antigen-Specific Hyporesponsiveness1 , 2002, The Journal of Immunology.
[26] H. Ploegh,et al. Mouse MHC class I tetramers that are unable to bind to CD8 reveal the need for CD8 engagement in order to activate naive CD8 T cells , 2002, European journal of immunology.
[27] D. Speiser,et al. Discrepancy between ELISPOT IFN-γ secretion and binding of A2/peptide multimers to TCR reveals interclonal dissociation of CTL effector function from TCR-peptide/MHC complexes half-life , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[28] L. Borysiewicz,et al. TCR signaling thresholds regulating T cell development and activation are dependent upon SHP-1. , 1999, Journal of immunology.
[29] R. Zinkernagel,et al. Peripheral clonal deletion of antiviral memory CD8+ T cells , 1993, European journal of immunology.
[30] M. Sadelain,et al. T cell–encoded CD80 and 4-1BBL induce auto- and transcostimulation, resulting in potent tumor rejection , 2007, Nature Medicine.
[31] D. Price,et al. Specificity of CTL interactions with peptide-MHC class I tetrameric complexes is temperature dependent. , 1999, Journal of immunology.
[32] Andrew K. Sewell,et al. Interaction between the CD8 Coreceptor and Major Histocompatibility Complex Class I Stabilizes T Cell Receptor-Antigen Complexes at the Cell Surface* , 2005, Journal of Biological Chemistry.
[33] D. Scheinberg,et al. Remodeling specific immunity by use of MHC tetramers: demonstration in a graft-versus-host disease model. , 2006, Blood.
[34] M. Glick,et al. Enhanced immunogenicity of CTL antigens through mutation of the CD8 binding MHC class I invariant region , 2007, European journal of immunology.
[35] Andrew K. Sewell,et al. The Human CD8 Coreceptor Effects Cytotoxic T Cell Activation and Antigen Sensitivity Primarily by Mediating Complete Phosphorylation of the T Cell Receptor ζ Chain* , 2001, The Journal of Biological Chemistry.
[36] A. Singer,et al. Association of the Adaptor Molecule Lat with Cd4 and Cd8 Coreceptors Identifies a New Coreceptor Function in T Cell Receptor Signal Transduction , 1999, The Journal of experimental medicine.
[37] H. Ploegh,et al. Class I negative CD8 T cells reveal the confounding role of peptide-transfer onto CD8 T cells stimulated with soluble H2-Kb molecules , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[38] Andrew K. Sewell,et al. The CD8 T Cell Coreceptor Exhibits Disproportionate Biological Activity at Extremely Low Binding Affinities* , 2003, Journal of Biological Chemistry.
[39] I. Messaoudi,et al. Direct Link Between mhc Polymorphism, T Cell Avidity, and Diversity in Immune Defense , 2002, Science.
[40] D. Speiser,et al. Functional Avidity of Tumor Antigen-Specific CTL Recognition Directly Correlates with the Stability of MHC/Peptide Multimer Binding to TCR1 , 2002, The Journal of Immunology.
[41] Richard A Koup,et al. T cell receptor recognition motifs govern immune escape patterns in acute SIV infection. , 2004, Immunity.
[42] O. Michielin,et al. CD3δ Establishes a Functional Link between the T Cell Receptor and CD8* , 2003, The Journal of Biological Chemistry.
[43] S. Hutchinson,et al. Anti-CD8 Antibodies Can Inhibit or Enhance Peptide-MHC Class I (pMHCI) Multimer Binding: This Is Paralleled by Their Effects on CTL Activation and Occurs in the Absence of an Interaction between pMHCI and CD8 on the Cell Surface 1 , 2003, The Journal of Immunology.
[44] R. Phillips,et al. Use of Peptide-Major Histocompatibility Complex Tetramer Technology To Study Interactions between Staphylococcus aureus Proteins and Human Cells , 2007, Infection and Immunity.
[45] P. Courtoy,et al. Restoring the association of the T cell receptor with CD8 reverses anergy in human tumor-infiltrating lymphocytes. , 2008, Immunity.
[46] M. Alexander-Miller,et al. Peptide Requirement for CTL Activation Reflects the Sensitivity to CD3 Engagement: Correlation with CD8αβ Versus CD8αα Expression1 , 2001, The Journal of Immunology.
[47] Rolf M. Zinkernagel,et al. Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells , 1993, Nature.
[48] C. Janeway,et al. Physical association of CD4 with the T cell receptor. , 1992, Journal of immunology.
[49] A. Sewell,et al. Protein kinase inhibitors substantially improve the physical detection of T-cells with peptide-MHC tetramers , 2009, Journal of immunological methods.
[50] S. Davis,et al. The structure and ligand interactions of CD2: implications for T-cell function. , 1996, Immunology today.
[51] Aaruni Khanolkar,et al. Maintenance, Loss, and Resurgence of T Cell Responses During Acute, Protracted, and Chronic Viral Infections1 , 2004, The Journal of Immunology.
[52] P. Klenerman,et al. Ultrasensitive Detection and Phenotyping of CD4+ T Cells with Optimized HLA Class II Tetramer Staining1 , 2005, The Journal of Immunology.
[53] A. Zajac,et al. Ablation of CD8 and CD4 T Cell Responses by High Viral Loads1 , 2003, The Journal of Immunology.
[54] A. McMichael,et al. The T cell repertoire in infection and vaccination: implications for control of persistent viruses. , 2007, Current opinion in immunology.
[55] Susan M. Drake. A Novel Approach. , 1996 .
[56] R. Phillips,et al. Control of HIV-1 immune escape by CD8 T cells expressing enhanced T-cell receptor , 2008, Nature Medicine.
[57] M. Alexander-Miller,et al. Dose‐dependent modulation of CD8 and functional avidity as a result of peptide encounter , 2007, Immunology.
[58] Cheng Zhu,et al. Kinetics of MHC-CD8 Interaction at the T Cell Membrane1 , 2007, Journal of Immunology.
[59] L. Stern,et al. Class II major histocompatibility complex tetramer staining: progress, problems, and prospects , 2008, Immunology.
[60] T. Schumacher,et al. MHC multimer technology: current status and future prospects. , 2005, Current opinion in immunology.
[61] N. Shastri,et al. Requirement for association of p56 lck with CD4 in antigen-specific signal transduction in T cells , 1991, Cell.
[62] David M Kranz,et al. Quantitative analysis of the contribution of TCR/pepMHC affinity and CD8 to T cell activation. , 2003, Immunity.
[63] A. Singer,et al. 'Coreceptor tuning': cytokine signals transcriptionally tailor CD8 coreceptor expression to the self-specificity of the TCR , 2007, Nature Immunology.
[64] B. Alarcón,et al. Coexistence of multivalent and monovalent TCRs explains high sensitivity and wide range of response , 2005, The Journal of experimental medicine.
[65] J. Frelinger,et al. Antigen-Specific Modulation of an Immune Response by In Vivo Administration of Soluble MHC Class I Tetramers1 , 2001, The Journal of Immunology.
[66] J. Altman,et al. Initiation of signal transduction through the T cell receptor requires the multivalent engagement of peptide/MHC ligands [corrected]. , 1998, Immunity.
[67] P. Klenerman,et al. Ultra‐sensitive class I tetramer analysis reveals previously undetectable populations of antiviral CD8+ T cells , 2004, European journal of immunology.
[68] Michael A. Bookman,et al. The CD4 and CD8 T cell surface antigens are associated with the internal membrane tyrosine-protein kinase p56 lck , 1988, Cell.
[69] C. Sharrock. T-cell repertoire. , 1988, Immunological Reviews.
[70] J. Frelinger,et al. Selective deletion of antigen-specific CD8+ T cells by MHC class I tetramers coupled to the type I ribosome-inactivating protein saporin. , 2007, Blood.
[71] C. Leclerc,et al. In Vivo Induction of a High-Avidity, High-Frequency Cytotoxic T-Lymphocyte Response Is Associated with Antiviral Protective Immunity , 2000, Journal of Virology.
[72] J. Berzofsky,et al. Role of antigen, CD8, and cytotoxic T lymphocyte (CTL) avidity in high dose antigen induction of apoptosis of effector CTL , 1996, The Journal of experimental medicine.
[73] C. Janeway. The T cell receptor as a multicomponent signalling machine: CD4/CD8 coreceptors and CD45 in T cell activation. , 1992, Annual review of immunology.
[74] D. Stuart,et al. Crystal structure of the complex between human CD8αα and HLA-A2 , 1997, Nature.
[75] S. Rowland-Jones,et al. Functional Discrepancies in HIV-Specific CD8+ T-Lymphocyte Populations Are Related to Plasma Virus Load , 2002, Journal of Clinical Immunology.
[76] Down-regulation of diabetogenic CD 4 + T cells by a soluble dimeric peptide – MHC-class-II chimera , 2002, Nature Reviews Immunology.
[77] S. Migueles,et al. Avidity for antigen shapes clonal dominance in CD8+ T cell populations specific for persistent DNA viruses , 2005, The Journal of experimental medicine.
[78] J. Frelinger,et al. tetramers coupled to the type I ribosome-inactivating protein saporin T cells by MHC class I + Selective deletion of antigen-specific CD8 , 2009 .
[79] H. Einsele,et al. Profound Inhibition of Antigen-Specific T-Cell Effector Functions by Dasatinib , 2008, Clinical Cancer Research.
[80] R. Phillips,et al. Antagonism of cytotoxic T lymphocyte‐mediated lysis by natural HIV‐1 altered peptide ligands requires simultaneous presentation of agonist and antagonist peptides , 1997, European journal of immunology.
[81] H. Reijonen,et al. Low‐avidity recognition by CD4+ T cells directed to self‐antigens , 2003, European journal of immunology.
[82] Jianzhu Chen,et al. Soluble peptide–MHC monomers cause activation of CD8+ T cells through transfer of the peptide to T cell MHC molecules , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[83] Philip J. R. Goulder,et al. Phenotypic Analysis of Antigen-Specific T Lymphocytes , 1996, Science.
[84] A. Trautmann,et al. CD8 expression allows T cell signaling by monomeric peptide-MHC complexes. , 1998, Immunity.
[85] J. Bluestone,et al. Peptide-MHC Class II Dimers as Therapeutics to Modulate Antigen-Specific T Cell Responses in Autoimmune Diabetes1 , 2003, The Journal of Immunology.
[86] M. Kester,et al. Investigation of Peptide Involvement in T Cell Allorecognition Using Recombinant HLA Class I Multimers1 , 2005, The Journal of Immunology.
[87] H. Rammensee,et al. Cutting Edge: Characterization of Allorestricted and Peptide-Selective Alloreactive T Cells Using HLA-Tetramer Selection1 , 2001, The Journal of Immunology.
[88] K. Eichmann,et al. Biochemical evidence of the physical association of the majority of CD3 δ chains with the accessory/co‐receptor molecules CD4 and CD8 on nonactivated T lymphocytes , 1992, European journal of immunology.
[89] S. Hutchinson,et al. Recognition of nonpeptide antigens by human Vγ9Vδ2 T cells requires contact with cells of human origin , 2004 .
[90] A. Sewell,et al. Coreceptor CD8-driven modulation of T cell antigen receptor specificity. , 2007, Journal of theoretical biology.
[91] D. Price,et al. Quantum dot semiconductor nanocrystals for immunophenotyping by polychromatic flow cytometry , 2006, Nature Medicine.
[92] P. A. van der Merwe,et al. T-cell receptor triggering is critically dependent on the dimensions of its peptide-MHC ligand , 2005, Nature.
[93] Ellis L. Reinherz,et al. Crystal structure of the human CD4 N-terminal two-domain fragment complexed to a class II MHC molecule , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[94] H. Rammensee,et al. Protective Immunity Does Not Correlate with the Hierarchy of Virus-specific Cytotoxic T Cell Responses to Naturally Processed Peptides , 1998, The Journal of experimental medicine.
[95] A. Sewell,et al. T cell receptor engagement of peptide-major histocompatibility complex class I does not modify CD8 binding. , 2008, Molecular immunology.
[96] M. Nishimura,et al. T-cell receptor tetramer binding or the lack there of does not necessitate antigen reactivity in T-cell receptor transduced T cells , 2006, Cancer Immunology, Immunotherapy.
[97] D. Douek,et al. Detection of low avidity CD8(+) T cell populations with coreceptor-enhanced peptide-major histocompatibility complex class I tetramers. , 2008, Journal of immunological methods.
[98] A. Sewell,et al. CD8 exerts differential effects on the deployment of cytotoxic T lymphocyte effector functions , 2007, European journal of immunology.
[99] A. Hamad,et al. Potent T Cell Activation with Dimeric Peptide–Major Histocompatibility Complex Class II Ligand: The Role of CD4 Coreceptor , 1998, The Journal of experimental medicine.
[100] R. Zamoyska,et al. Is CD8 dependence a true reflection of TCR affinity for antigen? , 1993, International immunology.
[101] R. Koup,et al. Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation. , 2003, Journal of immunological methods.
[102] E. Jaffee,et al. Direct visualization of antigen-specific T cells: HTLV-1 Tax11-19- specific CD8(+) T cells are activated in peripheral blood and accumulate in cerebrospinal fluid from HAM/TSP patients. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[103] S. Casares,et al. Down-regulation of diabetogenic CD4+ T cells by a soluble dimeric peptide–MHC class II chimera , 2002, Nature Immunology.
[104] I. Sakita,et al. In vivo CTL immunity can be elicited by in vitro reconstituted MHC/peptide complex. , 1996, Journal of immunological methods.
[105] J. Berzofsky,et al. Selective expansion of high- or low-avidity cytotoxic T lymphocytes and efficacy for adoptive immunotherapy. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[106] J. Frelinger,et al. Peripheral “CD8 Tuning” Dynamically Modulates the Size and Responsiveness of an Antigen-Specific T Cell Pool In Vivo1 , 2005, The Journal of Immunology.
[107] T. McKeithan,et al. Kinetic proofreading in T-cell receptor signal transduction. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[108] D. Legler,et al. Soluble Major Histocompatibility Complex-Peptide Octamers with Impaired CD8 Binding Selectively Induce Fas-dependent Apoptosis* 210 , 2003, The Journal of Biological Chemistry.
[109] G. Dolton,et al. Loss of Src Homology Region 2 Domain-Containing Protein Tyrosine Phosphatase-1 Increases CD8+ T Cell-APC Conjugate Formation and Is Associated with Enhanced In Vivo CTL Function1 , 2007, The Journal of Immunology.
[110] V. Appay,et al. A novel approach to antigen-specific deletion of CTL with minimal cellular activation using alpha3 domain mutants of MHC class I/peptide complex. , 2001, Immunity.
[111] B. Walker,et al. Analysis of Successful Immune Responses in Persons Infected with Hepatitis C Virus , 2000, The Journal of experimental medicine.
[112] A. Sewell,et al. Different T Cell Receptor Affinity Thresholds and CD8 Coreceptor Dependence Govern Cytotoxic T Lymphocyte Activation and Tetramer Binding Properties* , 2007, Journal of Biological Chemistry.
[113] S. Jameson,et al. Critical Role for Cd8 in T Cell Receptor Binding and Activation by Peptide/Major Histocompatibility Complex Multimers , 2000, The Journal of experimental medicine.
[114] B K Jakobsen,et al. T cell receptor and coreceptor CD8 alphaalpha bind peptide-MHC independently and with distinct kinetics. , 1999, Immunity.
[115] VEGF receptor signal transduction. , 2003, Science's STKE : signal transduction knowledge environment.
[116] M. Ostrowski,et al. Simian Immunodeficiency Virus (SIV) Infection of a Rhesus Macaque Induces SIV-Specific CD8+ T Cells with a Defect in Effector Function That Is Reversible on Extended Interleukin-2 Incubation , 2001, Journal of Virology.
[117] G. Ogg,et al. Cutting edge: rapid cloning of tumor-specific CTL suitable for adoptive immunotherapy of melanoma. , 1999, Journal of immunology.
[118] D. Speiser,et al. Fluorescence-Activated Cell Sorting and Cloning of Bona Fide CD8+ CTL with Reversible MHC-Peptide and Antibody Fab′ Conjugates1 , 2006, The Journal of Immunology.
[119] S. Rosenberg,et al. High avidity CTLs for two self-antigens demonstrate superior in vitro and in vivo antitumor efficacy. , 1999, Journal of immunology.
[120] P. Marrack,et al. Class II major histocompatibility complex-peptide tetramer staining in relation to functional avidity and T cell receptor diversity in the mouse CD4(+) T cell response to a rheumatoid arthritis-associated antigen. , 2005, Arthritis and rheumatism.
[121] D. Scheinberg,et al. Targeted deletion of T-cell clones using alpha-emitting suicide MHC tetramers. , 2004, Blood.
[122] C. Peota. Novel approach. , 2011, Minnesota medicine.
[123] M. Davis,et al. Isolation of high avidity melanoma-reactive CTL from heterogeneous populations using peptide-MHC tetramers. , 1999, Journal of immunology.